复星医药(600196.SH)：酮洛芬贴剂获临床试验批准

Core Viewpoint - Fosun Pharma's subsidiary, Shanghai Chaohui Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration to conduct clinical trials for the drug Ketorolac patch [1] Group 1 - The approval allows for the initiation of Phase III clinical trials for the Ketorolac patch in China once conditions are met [1]